Neuromodulation News and Research

RSS

A minimally invasive approach to managing pain without opioids

Researchers at the University of Wisconsin (UW) are adopting a minimally invasive, safer approach to electrically treating pain directly at the source as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.

19 May 2020

New noninvasive ultrasound neuromodulation technique for epilepsy treatment

Epilepsy is a central nervous system disorder characterized by recurrent seizures resulting from excessive excitation or inadequate inhibition of neurons.

15 May 2020

Researchers develop new method for remotely stimulating activity in deep brain regions

University of Texas at Dallas researchers have developed a promising method for remotely stimulating activity in deep brain regions, advancing understanding of how molecules act in the brain and paving the way for better cancer treatments and therapies for other diseases.

27 Apr 2020

New form of magnetic brain stimulation relieves symptoms of severe depression

A new form of magnetic brain stimulation rapidly relieved symptoms of severe depression in 90% of participants in a small study conducted by researchers at the Stanford University School of Medicine.

7 Apr 2020

Magnetic stimulation of rectal nerves could help treat fecal incontinence

An ongoing study by the Medical College of Georgia on the role of magnetic stimulation of the rectal nerves to achieve better bowel control in patients with fecal incontinence is showing early promise. The technique is called translumbosacral neuromodulation therapy, or TNT.

2 Apr 2020

Genetically modified neurons could enhance function of clinical implants

A team has genetically reprogrammed neurons that could enhance electrical implant function used in various clinical scenarios.

20 Mar 2020

New method could help facilitate transition of medical technology from lab to market

Advances in materials, microfabrication and medical imaging are accelerating the pace of innovation in implantable neuroprosthetics.

16 Mar 2020

New recommendations for evaluation of bladder and bowel dysfunction after spinal cord injury

Among the many challenges to independence and quality of life after spinal cord injury, two complications have emerged as top priorities for researchers - neurogenic bowel and neurogenic bladder.

12 Mar 2020

Clinical trial evaluates effectiveness of spinal cord stimulation in patients with overactive bladder

Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions, such as a spinal cord injury or stroke, and idiopathic (unknown) causes.

10 Mar 2020

Two cutting-edge programs in neuroplasticity come together for a synergistic impact in brain health

Abilities Neurological Rehabilitation is excited to announce a new, collaborative treatment program to help individuals in the Fraser Valley who are living with chronic physical and cognitive symptoms following brain injury.

27 Feb 2020

Study uses machine learning to identify personalized brain networks in kids

Machine learning is helping Penn Medicine researchers identify the size and shape of brain networks in individual children, which may be useful for understanding psychiatric disorders.

19 Feb 2020

Medtronic: RCT demonstrates profound back pain relief with DTM therapy

Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.

From Medtronic 27 Jan 2020

New neuromodulation device may help prevent migraine

If your bank account balance looks nail-bitingly low and you won't get paid for days, you might agonize over every dollar you spend. Maybe you'll scrutinize grocery-store ads more closely than usual or brew your own coffee instead of ordering it from a barista.

24 Jan 2020

Essential tremor caused by overactive brain waves

The source of essential tremor--a movement disorder that causes involuntary trembling of the hands, arms, and head--has been enigmatic, impeding the development of effective treatments for a condition that affects 4% of people over 40.

16 Jan 2020

Study reveals overactive brain wave activity as an underlying cause of essential tremor

Researchers at Columbia University Irving Medical Center say that overactive brainwave activity is the underlying cause of essential tremor – a common movement disorder that causes involuntary rhythmic shaking in around 4% of people aged over 40.

16 Jan 2020

Using caffeine to study how the brain processes information

Researchers are using caffeine to study how the brain processes information, and a new study shows the effectiveness of this approach.

13 Jan 2020

Epilepsy neurostimulators provide extra benefit by reducing neuropsychiatric comorbidities

People with drug-resistant epilepsy also can have deleterious neuropsychiatric symptoms like anxiety, depression, psychosis and impaired memory.

2 Jan 2020

Novela Neurotech’s “smart” neural interface displayed at Creative Destruction Lab

Novela Neurotech, a MedTech company developing AI-powered wireless, "smart" neural interface systems, joins Canada's Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders.

31 Dec 2019

IU researchers identify potential target to improve functional recovery after spinal cord injury

Researchers at Indiana University School of Medicine have made several novel discoveries in the field of spinal cord injuries. Most recently, the team led by Xiao-Ming Xu, PhD, has been working to determine how to activate movement after a spinal cord injury at the ninth thoracic level, where nerve fibers from the brain down to the spinal cord are interrupted.

22 Dec 2019

The role of adenosine in neurodegeneration and brain regeneration

The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis.

8 Dec 2019